These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19060532)

  • 1. Use of antibody induction in pediatric renal transplantation.
    Pescovitz MD
    Curr Opin Organ Transplant; 2008 Oct; 13(5):495-9. PubMed ID: 19060532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation.
    Sarwal MM; Vidhun JR; Alexander SR; Satterwhite T; Millan M; Salvatierra O
    Transplantation; 2003 Nov; 76(9):1331-9. PubMed ID: 14627912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-2 receptor blockade with humanized monoclonal antibody for solid organ transplantation.
    Campara M; Tzvetanov IG; Oberholzer J
    Expert Opin Biol Ther; 2010 Jun; 10(6):959-69. PubMed ID: 20415630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction immunosuppression with interleukin-2 receptor antibodies (basiliximab and daclizumab) in renal transplant recipients.
    Nair MP; Nampoory MR; Johny KV; Costandi JN; Abdulhalim M; El-Reshaid W; Al-Muzairai I; Ninan VT; Samhan M; Al-Mousawi M
    Transplant Proc; 2001 Aug; 33(5):2767-9. PubMed ID: 11498153
    [No Abstract]   [Full Text] [Related]  

  • 5. The CARI guidelines. Calcineurin inhibitors in renal transplantation: the addition of anti-CD25 antibody induction to standard immunosuppressive therapy for kidney transplant recipients.
    Webster AC;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S75-84. PubMed ID: 17316285
    [No Abstract]   [Full Text] [Related]  

  • 6. Renal transplantation in adolescents.
    Smith JM; McDonald RA
    Adolesc Med Clin; 2005 Feb; 16(1):201-14. PubMed ID: 15844392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal transplantation: a prospective, randomized study.
    Kandus A; Arnol M; Omahen K; Oblak M; Vidan-Jeras B; Kmetec A; Bren AF
    Transplantation; 2010 Apr; 89(8):1022-7. PubMed ID: 20075788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower risk of infectious deaths in cardiac transplant patients receiving basiliximab versus anti-thymocyte globulin as induction therapy.
    Mattei MF; Redonnet M; Gandjbakhch I; Bandini AM; Billes A; Epailly E; Guillemain R; Lelong B; Pol A; Treilhaud M; Vermes E; Dorent R; Lemay D; Blanc AS; Boissonnat P
    J Heart Lung Transplant; 2007 Jul; 26(7):693-9. PubMed ID: 17613399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in highly sensitized kidney transplant recipients.
    Munoz AS; Rioveros AA; Cabanayan-Casasola CB; Danguilan RA; Ona ET
    Transplant Proc; 2008 Sep; 40(7):2218-21. PubMed ID: 18790197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of monoclonal antibodies in renal transplantation.
    van den Hoogen MW; Hilbrands LB
    Immunotherapy; 2011 Jul; 3(7):871-80. PubMed ID: 21751955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Daclizumab and basiliximab: monoclonal mouse-man antibodies with effective immunosuppression without side effects].
    ter Meulen CG; Hilbrands LB; van Riemsdijk-van Overbeeke IC; Hené RJ; Christiaans MH; Hoitsma AJ
    Ned Tijdschr Geneeskd; 2000 Dec; 144(50):2396-400. PubMed ID: 11145094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basiliximab versus daclizumab combined with triple immunosuppression in deceased donor renal graft recipients.
    Grego K; Arnol M; Bren AF; Kmetec A; Tomaziĉ J; Kandus A
    Transplant Proc; 2007 Dec; 39(10):3093-7. PubMed ID: 18089329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basiliximab: a review of its use as induction therapy in renal transplantation.
    McKeage K; McCormack PL
    BioDrugs; 2010 Feb; 24(1):55-76. PubMed ID: 20055533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-T-cell antibodies for the treatment of acute rejection after renal transplantation.
    van den Hoogen MW; Hoitsma AJ; Hilbrands LB
    Expert Opin Biol Ther; 2012 Aug; 12(8):1031-42. PubMed ID: 22583145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of induction therapy in kidney transplantation.
    Hardinger KL; Brennan DC; Klein CL
    Transpl Int; 2013 Jul; 26(7):662-72. PubMed ID: 23279211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabbit antithymocyte globulin induction therapy in adult renal transplantation.
    Hardinger KL
    Pharmacotherapy; 2006 Dec; 26(12):1771-83. PubMed ID: 17125438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen.
    Yang SL; Wang D; Wu WZ; Lin WH; Xu TZ; Cai JQ; Tan JM
    Transpl Immunol; 2008 Jan; 18(3):281-5. PubMed ID: 18047938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daclizumab versus anti-thymocyte globulin-fresenius as induction therapy for low-risk kidney transplant recipients.
    Abou-Jaoude MM; Ghantous I; Najm R; Afif C; Almawi WY
    Transplant Proc; 2003 Nov; 35(7):2731-2. PubMed ID: 14612096
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interleukin-2 receptor blockers in renal transplantation].
    Basić-Jukić N; Bubić-Filipi L; Danić A; Pasini J; Kes P
    Acta Med Croatica; 2004; 58(5):395-9. PubMed ID: 15756806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monoclonal interleukin-2 receptor antibodies and their use in clinical kidney transplantation: basiliximab and daclizumab].
    Madsen M; Svendsen UG
    Ugeskr Laeger; 2000 Oct; 162(42):5648-52. PubMed ID: 11059309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.